abstract |
FIELD: medicine. n SUBSTANCE: what is offered is application of 9-(3,4-dihydroxyphenacyl)-2,3-dihydroimidazo[1,2-a] benzimidazole hydrobromide of formula I as a compound possessing antithrombogenic activity. The compound is applicable as an active principle of drugs for therapy of thromboses. Activity of the compound exceeds acetylsalicylic acid and diabenol. n EFFECT: higher antithrombogenic activity in the conditions of arterial thrombosis. n 2 cl, 6 tbl, 4 ex |